Search This Blog

Thursday, April 30, 2026

Merit updates 2026 guidance for View Point Medical acquisition

 

Merit Medical posts Q1 2026 revenue $381.9M, non-GAAP EPS $0.94, updates 2026 guidance for View Point Medical acquisition

  • Full-year 2026 guidance now reflects modest revenue contribution and EPS dilution from the View Point Medical acquisition.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)